Small Pharma

Agentic AI for Small Pharma

Small pharma organizations managing 1–10concurrent trials face a critical execution gap at the most capital-sensitivestage of development.

Most lack internal biometrics infrastructureand rely heavily on CRO delivery. Traditional models -$2–10M programs with 12–24 month timelines-consume runway, while building in-house teams requires 12-18 months. Multi-vendor coordination across data, programming, and medicalwriting introduces variability that lean teams cannot absorb.

Theissue is not ambition. It is the ability to execute without buildinginfrastructure

Talk to Experts

Agentic AI Offerings

Our platform strengthens execution across critical workflows:

Study Startup Support

Faster startup readiness

Improved activation tracking

Clinical Data Management

Automated data cleaning

Faster database readiness

Statistical Programming Support

Automated dataset preparation

Improved biometrics efficiency

Operational Oversight

Continuous monitoring across trials

Earlier risk detection

Where Small Pharma Execution Slows

Execution challenges commonly occur due to:

Limited internal operational capacity

Heavy dependence on CRO delivery

Delays in biometrics workflows

Limited real-time execution visibility

Small teams managing complex workflows

These constraints slow execution predictability.

What Improves with Agentic AI

With agentic AI for small pharma, execution becomes more scalable:

Faster database readiness timelines

Reduced dependency on manual workflows

Earlier risk detection

Improved operational visibility

Recommended approach: deploy supervised execution capacity at the Phase 1 to Phase 2 transition - when complexity increases but teams remain lean. Organizations that do this advance to database lock 40–50% faster while preserving runway and avoiding internal team expansion.